Safety and efficacy of imatinib in CML over a period of 10 years: data from the randomized CML-study IV

Lida Kalmanti; Susanne Saußele; Michael Lauseker; M. C. Muller; Christian Dietz; Linda Heinrich; Benjamin Hanfstein; Ulrike Proetel; Alice Fabarius; Stefan W. Krause; Sébastien Rinaldetti; Jolanta Dengler; Christiane Falge; Elisabeth Oppliger Leibundgut; Andreas Burchert; Andreas Neubauer; Lothar Kanz; Frank Stegelmann; Michael Pfreundschuh; Karsten Spiekermann; Christof Scheid; Markus Pfirrmann; Andreas Hochhaus; Joerg Hasford; R. Hehlmann; for the SAKK and the German CML Study-Group

doi:10.1038/leu.2015.36

Safety and efficacy of imatinib in CML over a period of 10 years: data from the randomized CML-study IV | Litlas